A LEADING MEDICAL RESEARCH INSTITUTE SPECIALISING IN ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Alzheimer’s Research Australia
With Professor Vicky Vass, Chief Executive Officer
ORGANISATIONS IN MEDICAL RESEARCH
Filmed in Perth, Western Australia | November 2024
Professor Vicky Vass serves as the Chief Executive Officer of Alzheimer’s Research Australia, which is based in Perth, Western Australia. Australian Health Journal met with Professor Vass to hear of the organisation’s mission to solve the mysteries surrounding Alzheimer’s disease, and focus on detection as the key to their efforts.
Founded in 1993, the organisation now comprises a large research team, a clinical trials division, and an administrative support team. Their aim is to make Alzheimer’s a distant memory through rigorous research.
Their philosophy revolves around operating as one cohesive team, which includes all these parts as well as the board, fostering effective collaboration. Leading this team is Professor Ralph Martins AO, as the Chief Inspector in their mission. He focuses on uncovering pathways for prevention, intervention, and the latest treatments for neurodegenerative diseases.
Among the key studies highlighted by Professor Vass is the blood biomarker study led by Professor Ralph Martins, which aims to develop a cost-effective method for detecting Alzheimer’s through a simple blood test. Currently, detection methods involve multiple scans and intense processes, but this initiative could transform the landscape by making detection more accessible and affordable.
Another study is run by Dr. Prashant Bharadwaj who heads the research on childhood dementia, focusing on providing hope to the youngest patients affected by these debilitating diseases. His work is dedicated to ensuring that children have a future filled with memories rather than loss, striving to find ways to detect and ultimately cure childhood dementia.
The board of Alzheimer’s Research Australia comprises a diverse group of individuals, including academics and those involved in commercial work and aged care. The common goal uniting them is to find a cure for Alzheimer’s disease. Funding for the organisation primarily comes from donations and rely heavily on this support, as they do not receive significant government funding, although they do get some grants for research.
Professor Vass describes Alzheimer’s Research Australia as an incredible place to work, boasting a community akin to a family. Every role within the organisation is respected, contributing to a common goal of making Alzheimer’s a distant memory for future generations.
-
Op-Ed: CGT and proposed RDTI changes creating uncertainty in life sciences
Proposed Budget changes to the Research and Development Tax Incentive (RDTI) will disproportionally impact Australia’s biotech, medtech and health tech sector forcing more home-grown companies to consider moving overseas.
-
HIGHLIGHTS The power of social determinants of health, panel discussion
Clinicians and consumers know only too well that life circumstances such as poor housing, income and food insecurity can have a negative impact on health outcomes. Conversely, participation in community activities, social connection and access to nature parks and leisure facilities can help maintain health and wellbeing.
More recent phenomena in public health have also focused us on the health and social care connection. Stress factors such as the sudden loss of employment and social interaction, moving to remote work or schooling, and the impacts of sudden, localised COVID-19 ‘lockdowns’ to prevent further outbreaks were triggers of increased psychological distress.
And loneliness is being described as our latest epidemic with chronic loneliness inked to a myriad of health problems and earlier death. A recent report found one in four Australians say they feel persistently lonely, and that loneliness costs $2.7 bn a year in health costs alone.
-
Family biz succeeds in vaccine approval & distribution
It’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia.
In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations.
